Blood pressure reduction
A head-to-head RCT versus captopril (an ACE inhibitor pharmaceutical) showed olive leaf extract (500 mg twice daily, standardized to oleuropein) was equivalent in blood pressure-lowering efficacy to captopril 12.5 mg twice daily over 8 weeks — reducing systolic BP by 11.5 mmHg and diastolic by 4.8 mmHg in stage 1 hypertension patients.
Cardiovascular and endothelial protection
Hydroxytyrosol (the gut metabolite of oleuropein) has EFSA-approved health claims for protection of LDL from oxidative damage. Olive polyphenols improve endothelial function, reduce ICAM-1 and VCAM-1 adhesion molecules, and decrease platelet aggregation — providing comprehensive cardiovascular protection.
Blood sugar and insulin regulation
Olive leaf extract significantly reduces fasting blood glucose, postprandial glucose, and insulin resistance in pre-diabetic and type 2 diabetic patients. Alpha-glucosidase inhibition and improved peripheral insulin sensitivity are the primary mechanisms, with effects comparable to some oral hypoglycemic agents.
Antiviral and antimicrobial activity
Oleuropein and its metabolite elenolic acid have demonstrated antiviral activity against influenza, herpes, HIV, hepatitis, and respiratory viruses in laboratory studies. The mechanism involves disruption of viral envelope glycoproteins required for host cell attachment and penetration.
Anti-inflammatory and antioxidant
Hydroxytyrosol is one of the most potent known natural antioxidants by ORAC measurement, with free radical scavenging activity exceeding resveratrol and vitamin E. Oleuropein inhibits NF-κB, COX-2, and 5-LOX pathways, providing broad-spectrum anti-inflammatory activity.
ACE inhibition and vasodilation
Oleuropein and hydroxytyrosol inhibit angiotensin-converting enzyme (ACE) — the same target as captopril and lisinopril. ACE inhibition reduces angiotensin II production, decreasing vasoconstriction and aldosterone release, leading to blood pressure reduction and improved renal function.
GLUT4 translocation and insulin sensitization
Oleuropein activates AMPK and promotes GLUT4 glucose transporter translocation to the cell membrane independently of insulin signaling, improving skeletal muscle glucose uptake and insulin sensitivity — a mechanism shared with metformin but through a different upstream pathway.
LDL oxidation prevention
Hydroxytyrosol integrates into LDL particle membranes and directly prevents oxidative modification of LDL cholesterol by reactive oxygen species — the initiating event in atherosclerotic plaque formation. This is the basis of the EFSA-approved cardiovascular health claim for olive polyphenols.
Randomized, double-blind, parallel trial comparing olive leaf extract (500 mg twice daily) vs. captopril (12.5 mg twice daily) in 80 twins with stage 1 hypertension for 8 weeks.
80 adult twins with stage 1 hypertension. 8-week parallel design.
Olive leaf extract produced equivalent blood pressure reductions to captopril (−11.5/−4.8 mmHg vs −13.7/−6.4 mmHg). Comparable lipid-lowering effects. Better tolerability — no cough (common captopril side effect). First head-to-head botanical vs. pharmaceutical blood pressure trial.
Randomized, double-blind crossover trial of olive leaf extract (51.1 mg oleuropein + 9.7 mg hydroxytyrosol/day) vs. placebo in 46 overweight middle-aged men for 12 weeks.
46 overweight men. 12-week crossover design.
Olive leaf extract significantly improved insulin sensitivity (29% improvement in HOMA-IR) and pancreatic beta-cell responsiveness (28% improvement). Reduction in visceral fat. Well-tolerated.